Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.3M 2.05M 1.9M 1.72M 3.23M 217M 3.27M 22.75M 8.92M 114M 8.63M 8.45M 363M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 2.38M 2.12M 1.96M 1.78M 3.35M 225M 3.39M 23.54M 9.24M 118M 8.93M 8.74M 376M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.3M | |
| -0.21% | -6.36% | +49.00% | +74.13% | 66.34B | |
| -0.22% | +6.53% | +11.68% | +90.35% | 52.92B | |
| +0.82% | +5.41% | +8.05% | +74.45% | 54.82B | |
| +3.27% | +5.53% | +26.45% | +50.51% | 44.09B | |
| +0.44% | +9.86% | +22.30% | +128.84% | 43.72B | |
| -0.89% | +1.35% | +266.67% | +968.54% | 42.13B | |
| +0.10% | +9.96% | +17.15% | +59.33% | 33.96B | |
| -1.30% | -3.61% | +37.37% | +7.16% | 26.17B | |
| +0.69% | +5.60% | +36.60% | +26.39% | 23.37B | |
| Average | +0.24% | +4.78% | +52.81% | +164.41% | 43.06B | |
| Weighted average by Cap. | +0.29% | +4.67% | +51.87% | +168.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 163K 151K 137K 257K 17.27M 260K 1.81M 710K 9.08M 686K 672K 28.93M | - |
| Net income | -7.23M -6.44M -5.97M -5.4M -10.17M -682M -10.29M -71.54M -28.07M -359M -27.13M -26.56M -1.14B | -2.89M -2.58M -2.39M -2.16M -4.07M -273M -4.12M -28.61M -11.22M -143M -10.85M -10.62M -457M |
| Net Debt | 478K 426K 394K 357K 672K 45.11M 680K 4.73M 1.86M 23.71M 1.79M 1.76M 75.55M | 80K 71.29K 66K 59.73K 113K 7.55M 114K 791K 311K 3.97M 300K 294K 12.64M |
Employees
-
